Table 4 Univariate analysis of factors associated with anxiety and depression

Age < 50

-0.144

-1.23, 0.94

0.795

1.472

0.41, 2.53

0.007

Health sector: Private /Public

0.256

-1.06, 1.57

0.702

-0.101

-1.40, 1.20

0.878

Living area : Urban /Rural

-0.039

-1.13, 1.05

0.944

0.548

-1.88, 0.27

0.144

Level of education

unschooled

Primary

Secondary

High school

1.647

2.338

-0.647

Ref

-0.42, 3.72

0.04, 4.63

-3.42, 2.13

0.118

0.046

0.646

1.914

3.212

-0.059

Ref

-0.12, 3.95

0.95, 5.47

-2.79, -2.67

0.065

0.006

0.966

Medical coverage

-1.031

-3.57, 1.50

0.424

0.538

-1.98, 3.05

0.674

Marital status

married

Widowed

Divorced

single

Ref

0.147

2.329

0.784

-1.83, 2.12

0.48, 4.18

-0.77, 2.34

0.883

0.014

0.323

Ref

-0.955

2.409

0.924

-2.90, 0.99

0.58, 4.23

-0.61, 2.46

0.335

0.010

0.237

Living conditions: Family/Other

-3.058

-5.29, -0.83

0.007

-3.016

-5.23, -0.80

0.008

Socioeconomic level

Low

average

High

Ref

-0.254

-1.727

-2.27, 1.76

-4.16, 0.71

0.804

0.164

Ref

-0.269

-1.242

-2.27, -1.73

-3.66, -1.18

0.791

0.313

Occupational status

Inactive

Loss of work

Active

0.357

0.067

Ref

-0.94, 1.66

-2.49, 2.63

0.588

0.959

0.896

1.388

Ref

-1.64, -3.43

-1.31, -4.08

0.487

0.312

Financial support received

-1.226

-2.40, -0.05

0.040

-1.211

-2.37, -0.05

0.041

Minor children in charge

0.838

-0.24, 1.92

0.127

1.630

0.58, 2.68

0.003

Age of children

No child

< 10 years

10–18 years

major

1.383

1.224

1.683

Ref

-0.13, 2.90

-0.39, 2.84

0.25, 3.12

0.073

0.137

0.022

2.585

2.589

3.060

Ref

1.13, 4.03

1.04, 4.14

1.69, 4.43

< 0.001

0.001

< 0.001

Comorbidity

0.784

-0.36, 1.92

0.177

0.026

-1.11, 1.16

0.964

Family history of cancer

0.370

-0.74, 1.48

0.512

-0.225

-1.33, -0.88

0.688

Physical activity

-3.614

-5.48, -1.75

< 0.001

-2.452

-4.33, -0.57

0.011

Time since diagnosis

0.047

0.003, 0.09

0.036

0.055

0.01, 0.10

0.014

Histological type

Infiltrating carcinoma

In situ carcinoma

Other

2.077

3.333

Ref

-1.32, 5.47

-3.37, 10.03

0.229

0.328

5.320

4.000

Ref

-0.43, 11.07

-2.61, 10.61

0.069

0.234

Molecular type

Luminal A

Luminal B

HER+

Triple negative

Non-class

1.014

-0.192

1.767

2.150

Ref

-2.40, 4.43

-3.64, 3.25

-1.86, 5.39

-1.46, 5.76

0.559

0.912

0.338

0.242

0.362

-0.467

1.433

1.618

Ref

-3.03, 3.76

-3.89, 2.96

-2.17, 5.04

-1.97, 5.21

0.834

0.788

0.434

0.376

SBR grade

Grade I

Grade II

Grade III

Ref

1.112

1.830

-2.62, 4.85

-1.92, 5.58

0.558

0.338

Ref

2.856

3.420

-0.83, 6.55

-0.29, 7.13

0.129

0.071

TNM Stage

Stage I-II

Stage III

Stage IV

Ref

1.468

3.688

-

0.31, 2.63

2.20, 5.18

0.013

< 0.001

Ref

1.827

3.703

0.69, 2.96

2.25, 5.16

0.002

< 0.001

Chemotherapy

-1.311

-7.14, 4.52

0.658

5.285

-0.46, 11.03

0.071

Hormonotherapy

-0.762

-1.84, 0.32

0.166

0.409

-0.67, 1.48

0.454

Targeted therapy

-1.008

-2.09, 0.08

0.068

-0.848

-1.92, 0.23

0.122

Radiotherapy

0.092

-1.19, 1.37

0.887

-0.172

-1.44, 1.09

0.790

Surgery

Lumpectomy

Mastectomy

No

Ref

1.465

2.333

0.11, 2.81

0.35, 4.32

0.034

0.021

Ref

1.306

2.513

-0.03, 2.64

0.55, 4.48

0.056

0.012

Recurrence

5.420

3.34, 7.50

< 0.001

3.738

1.62, 5.86

< 0.001

Social support

Satisfaction

Availability

-0.348

-0.258

-0.40, -0.29

-0.33, -0.18

< 0.001

< 0.001

-0.293

-0.221

-0.35, -0.23

-0.30, -0.15

< 0.001

< 0.001

Karnofsky

-0.179

-0.22, -0.14

< 0.001

-0.127

-0.17, -0.09

< 0.001